Fahad Khaliq/X
Jan 7, 2026, 08:50
Fahad Khaliq on When is Ticagrelor Preferred Over Other Antiplatelets
Fahad Khaliq, Doctor of Medicine at Allied Hospital, Faisalabad, reposted from Muhammad Moor on X:
”Faster, potent, better, reversible, better mortality results
But here’s the plot twist!
If a patient is already on anticoagulation/high risk bleed, Clopidogrel is preferred
Rule of thumb:
• STEMI pt undergoing PCI: Ticagrelor
• STEMI pt undergoing Thrombolysis: Clopidogrel”
Quoting Muhammad Moor‘s post:
”Why is Ticagrelor sometimes preferred over other antiplatelets in acute coronary syndrome (ACS)?”

Stay updated with Hemostasis Today.
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation
-
Nov 8, 2026, 05:34Eugene Bolotin: Thrombosis and Survival in Pancreatic Cancer